Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
09/27/2012 | US20120245108 Method of modulating complement factor b (cfb) expression in cells |
09/27/2012 | US20120245081 Fas peptide mimetics and uses thereof |
09/27/2012 | US20120245080 Mineral salt-sulfonic acid compositions and methods of use |
09/27/2012 | US20120244216 Coated pharmaceutical capsule dosage form |
09/27/2012 | US20120244191 Compositions and methods for controlling diseases in animals |
09/27/2012 | US20120244190 Vaccination of Sex Reversed Hybrid Tilapia (Oreochromis niloticus X O. aureus) With an Inactivated Vibrio vulnificus Vaccine |
09/27/2012 | US20120244189 Treatment of infections |
09/27/2012 | US20120244185 Immunization strategy to prevent h1n1 infection |
09/27/2012 | US20120244183 Influenza viruses and uses thereof |
09/27/2012 | US20120244181 Creating bioengineered lymph nodes |
09/27/2012 | US20120244180 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same |
09/27/2012 | US20120244178 Plasmodium falciparum antigens |
09/27/2012 | US20120244176 Protein having immunogenicity of cedar pollen, polynucleotide encoding the protein, and use thereof |
09/27/2012 | US20120244175 Tumor specific animal proteins |
09/27/2012 | US20120244174 Treatment of tauopathies |
09/27/2012 | US20120244171 Cytotoxic benzodiazepine derivatives |
09/27/2012 | US20120244162 Cross-species-specific bispecific binders |
09/27/2012 | US20120244155 Dendritic Cells (DCs) Targeting for Tuberculosis (TB) Vaccine |
09/27/2012 | US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use |
09/27/2012 | US20120244148 Anti-interferon-alpha antibodies |
09/27/2012 | US20120244145 Enhanced immunological responses |
09/27/2012 | US20120244118 Conjugates and compositions for immunotherapy and anti-tumoral treatment |
09/27/2012 | US20120244117 Method of reversing immune suppression of langerhans cells |
09/27/2012 | US20120244113 Immunogenic composition and methods |
09/27/2012 | CA2830987A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine |
09/27/2012 | CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
09/27/2012 | CA2829916A1 Rapid and prolonged immunologic-therapeutic |
09/27/2012 | CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
09/27/2012 | CA2820956A1 Methods and compositions comprising il-7 receptor ligands |
09/26/2012 | EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile |
09/26/2012 | EP2501407A1 Anti-orai1 antigen binding proteins and uses thereof |
09/26/2012 | EP2501382A1 Apremilast for the treatment of sarcoidosis |
09/26/2012 | CN1674933B 疫苗组合物 Vaccine compositions |
09/26/2012 | CN102695722A Antibodies and epitopes specific to misfolded prion protein |
09/26/2012 | CN102695710A Tricyclic pyrazol amine derivatives |
09/26/2012 | CN102695697A Novel multifunctional peptidase inhibitors, especially for medical use |
09/26/2012 | CN102695522A New human rotavirus strains and vaccines |
09/26/2012 | CN102695519A Breakfast cereals containing probiotic micro organisms |
09/26/2012 | CN102690445A Mycobacterium polysaccharide, its preparation method and application |
09/26/2012 | CN102690368A Preparation method of yeast beta-1,3-D-glucan derivative |
09/26/2012 | CN102690366A Preparation method of plant polysaccharide sulfate with immune enhanced activity and anti-virus effect, as well as application |
09/26/2012 | CN102690340A Recombined Brazil nut allergen and mutant and preparation method and applications thereof |
09/26/2012 | CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors |
09/26/2012 | CN102690234A Novel crystal forms of substituted phenylalkanoic acids and process for producing the same |
09/26/2012 | CN102688334A Chinese and western medicine mixture for improving immunologic function of livestock and preparation method thereof |
09/26/2012 | CN102688323A Chinese veterinary drug granule for improving immunologic function of livestock and preparation method thereof |
09/26/2012 | CN102688321A Traditional Chinese medicine preparation improving health of nursing sows and piglets thereof by maternal therapy |
09/26/2012 | CN102688316A Livestock compound medicine with anti-virus and immune regulation functions |
09/26/2012 | CN102688283A Chinese traditional medicine capsule for treating lupus erythematosus and preparation method thereof |
09/26/2012 | CN102688265A Okra-containing antivirus granular electuary |
09/26/2012 | CN102688255A Application of polysaccharides extracted from wild chrysanthemum in preparation of medicine for enhancing body immunity |
09/26/2012 | CN102688238A Montelukast sodium combination drug granules for treating asthma, and application thereof |
09/26/2012 | CN102336739B Loratadine compound and preparation method thereof |
09/26/2012 | CN102327220B Solid loratadine lipidosome preparation |
09/26/2012 | CN102296016B Health-care wine containing Shuanghuanglian injection and preparation method thereof |
09/26/2012 | CN102091100B Method for improving main medicinal ingredients through solid fermentation of Indian buead and cordyceps militaris |
09/26/2012 | CN101912485B Medicinal composition having functions of resisting inflammation and easing pain and preparation method and application thereof |
09/26/2012 | CN101904864B Application of silicone oil in preparing allergen retarder |
09/26/2012 | CN101611015B Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
09/26/2012 | CN101460067B Induction of tolerance to egg proteins |
09/26/2012 | CN101357883B Antrodia camphoratea pimelie kelone compound for treating autoimmune disease and medicine composition |
09/26/2012 | CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies |
09/26/2012 | CN101120955B Enteric coated preparation containing glossy ganoderma spore powder active ingredient |
09/26/2012 | CN101119743B Immunopotentiating agent |
09/25/2012 | US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them |
09/25/2012 | US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
09/25/2012 | US8273356 Anti-IgE vaccines |
09/25/2012 | US8273350 Antibodies to human IL-1β |
09/25/2012 | CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
09/25/2012 | CA2496688C Glycinamide derivatives as raf-kinase inhibitors |
09/25/2012 | CA2489427C Combination of azelastine and steroids |
09/25/2012 | CA2323681C Development of human monoclonal antibodies and uses thereof |
09/25/2012 | CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses |
09/20/2012 | WO2012126013A2 Method for making pluripotent stem cells |
09/20/2012 | WO2012125893A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
09/20/2012 | WO2012125887A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
09/20/2012 | WO2012125886A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
09/20/2012 | WO2012125720A2 Polypeptides having immunoactivating activity and methods of producing the same |
09/20/2012 | WO2012125680A1 Methods of treating vasculitis using an il-17 binding molecule |
09/20/2012 | WO2012125629A1 Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors |
09/20/2012 | WO2012125567A2 Vaccine formulation of mannose coated peptide particles |
09/20/2012 | WO2012125475A1 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2-6-dione in treatment of immune-related and inflammatory diseases |
09/20/2012 | WO2012125413A2 Compositions for ameliorating systemic inflammation and methods for making and using them |
09/20/2012 | WO2012125071A1 1,3-diethylbenzimidazole salts - immunostimulating agents and pharmaceutical compositions on the basis thereof |
09/20/2012 | WO2012124817A1 Sprouted cereal, method for manufacturing same, food product containing same, and bdnf production accelerator |
09/20/2012 | WO2012124743A1 Method for producing polygonum tinctorium extract |
09/20/2012 | WO2012124738A1 Bleomycin hydrolase production promoting agent |
09/20/2012 | WO2012124696A1 Guanidine compound |
09/20/2012 | WO2012124631A1 Adjuvant composition containing citrulline |
09/20/2012 | WO2012123938A1 Quinolone analogs for treating autoimmune diseases |
09/20/2012 | WO2012123755A1 Re-directed immunotherapy |
09/20/2012 | WO2012123493A2 Isoxazolidine derivatives |
09/20/2012 | WO2012123482A2 Isoxazolidine derivatives |
09/20/2012 | WO2012123381A1 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders |
09/20/2012 | WO2012123312A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors |
09/20/2012 | WO2012123311A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
09/20/2012 | WO2012123269A1 Immunogenic compositions and methods for their use |
09/20/2012 | WO2012122931A1 Paecilomyces tenuipes strain and applications thereof |
09/20/2012 | WO2012122629A1 A method of vaccination comprising a histone deacetylase inhibitor |
09/20/2012 | WO2012122618A1 Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response |